BBC vs. VPC
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and VPC (Virtus Private Credit ETF) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while VPC is a Nontraditional Bonds fund tracking the Indxx Private Credit Index. Both are passively managed. Over the past 5 years, BBC returned -2.05%/yr vs 1.59%/yr for VPC. At a 0.36 correlation, their price movements are largely independent. BBC charges 0.79%/yr vs 0.75%/yr for VPC.
Performance
BBC vs. VPC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 8.17% return, which is significantly higher than VPC's -7.51% return.
BBC
- 1D
- -4.90%
- 1M
- -4.81%
- YTD
- 8.17%
- 6M
- 20.12%
- 1Y
- 123.11%
- 3Y*
- 19.82%
- 5Y*
- -2.05%
- 10Y*
- 7.60%
VPC
- 1D
- -0.53%
- 1M
- -3.41%
- YTD
- -7.51%
- 6M
- -7.59%
- 1Y
- -11.00%
- 3Y*
- 3.51%
- 5Y*
- 1.59%
- 10Y*
- —
BBC vs. VPC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.17% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 49.69% |
VPC Virtus Private Credit ETF | -7.51% | -6.75% | 10.52% | 22.20% | -11.70% | 34.18% | -9.50% | 9.32% |
Correlation
The correlation between BBC and VPC is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Feb 11, 2019 | 0.36 |
The correlation between BBC and VPC shifts across timeframes, from 0.21 (1 year) to 0.38 (5 years), reflecting how their relationship changes across market environments.
BBC vs. VPC - Sectors Allocation Comparison
Sectors
BBC
VPC
Healthcare
Basic Materials
-
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
BBC
VPC
Basic Materials
BBC
-
VPC
-
Communication Services
BBC
-
VPC
Consumer Cyclical
BBC
-
VPC
Consumer Defensive
BBC
-
VPC
-
Energy
BBC
-
VPC
Financial Services
BBC
-
VPC
Industrials
BBC
-
VPC
Real Estate
BBC
-
VPC
-
Technology
BBC
-
VPC
Utilities
BBC
-
VPC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. VPC — Risk / Return Rank
BBC
VPC
BBC vs. VPC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Virtus Private Credit ETF (VPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBC | VPC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.49 | -0.85 | +4.34 |
Sortino ratioReturn per unit of downside risk | 4.11 | -1.13 | +5.25 |
Omega ratioGain probability vs. loss probability | 1.48 | 0.87 | +0.61 |
Calmar ratioReturn relative to maximum drawdown | 8.82 | -0.50 | +9.32 |
Martin ratioReturn relative to average drawdown | 28.55 | -1.00 | +29.55 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBC | VPC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.49 | -0.85 | +4.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.12 | -0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 0.21 | -0.10 |
Drawdowns
BBC vs. VPC - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than VPC's maximum drawdown of -53.45%. Use the drawdown chart below to compare losses from any high point for BBC and VPC.
Loading charts...
Drawdown Indicators
| BBC | VPC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -53.45% | -23.40% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -22.76% | +7.66% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -24.86% | -29.59% |
Max Drawdown (5Y)Largest decline over 5 years | -72.44% | -24.86% | -47.58% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | — | — |
Current DrawdownCurrent decline from peak | -30.57% | -18.08% | -12.49% |
Average DrawdownAverage peak-to-trough decline | -37.14% | -7.67% | -29.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.66% | 11.40% | -6.74% |
Volatility
BBC vs. VPC - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 11.21% compared to Virtus Private Credit ETF (VPC) at 2.78%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than VPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | VPC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | 2.78% | +8.43% |
Volatility (6M)Calculated over the trailing 6-month period | 26.65% | 10.70% | +15.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.74% | 13.04% | +22.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.31% | 13.48% | +25.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.75% | 20.55% | +17.20% |
BBC vs. VPC - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than VPC's 0.75% expense ratio.
Dividends
BBC vs. VPC - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.57%, less than VPC's 16.97% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
VPC Virtus Private Credit ETF | 16.97% | 14.33% | 11.26% | 11.71% | 10.74% | 6.31% | 10.06% | 8.19% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBC and VPC have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (11.21%) compared to VPC (2.78%). In terms of maximum drawdown, BBC dropped -76.85% vs VPC's -53.45%.
On 5-year performance, VPC leads with 1.59% vs -2.05% for BBC. On fees, VPC is cheaper at 0.75% per year. On volatility, VPC has been the lower-risk option at 2.78%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, VPC has performed better with a 1.59% return vs -2.05%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VPC is cheaper with a 0.75% expense ratio, compared with 0.79% for BBC.
VPC has the higher dividend yield at 16.97%, compared with 1.57% for BBC.
BBC is categorized as Health & Biotech Equities, while VPC is Nontraditional Bonds. BBC tracks LifeSci Biotechnology Clinical Trials Index, while VPC tracks Indxx Private Credit Index. Their fees differ too: 0.79% for BBC and 0.75% for VPC.
BBC currently has the higher Sharpe Ratio (3.49 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and VPC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer